Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/198655
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarampitsakos, Theodoros-
dc.contributor.authorDiep, Phuong Phuong-
dc.contributor.authorLoth, Daan W.-
dc.contributor.authorNadeem, Iftikhar-
dc.contributor.authorKhurtsidze, Elene-
dc.contributor.authorWijsenbeek, Marlies S.-
dc.contributor.authorWuyts, Wim A.-
dc.contributor.authorBargagli, Elena-
dc.contributor.authorFroidure, Antoine-
dc.contributor.authorSpagnolo, Paolo-
dc.contributor.authorVeltkamp, Marcel-
dc.contributor.authorMolina Molina, Maria-
dc.contributor.authorMccarthy, Cormac-
dc.contributor.authorAntoniou, Katerina M.-
dc.contributor.authorKreuter, Michael-
dc.contributor.authorMoor, Catharina C.-
dc.date.accessioned2023-05-30T12:26:34Z-
dc.date.available2023-05-30T12:26:34Z-
dc.date.issued2023-01-05-
dc.identifier.issn2312-0541-
dc.identifier.urihttp://hdl.handle.net/2445/198655-
dc.description.abstractThis article contains a selection of scientific highlights in the field of interstitial lung diseases (ILDs) presented at the hybrid European Respiratory Society International Congress 2022. Early Career Members of Assembly 12 summarise recent advances in translational and clinical research in idiopathic interstitial pneumonias, ILDs of known origin, sarcoidosis and other granulomatous diseases, and rare ILDs. Many studies focused on evaluation of diagnostic and prognostic (bio)markers, and novel pharmacological and nonpharmacological treatment options for different ILDs. In addition, new insights in clinical, physiological and radiological features of various rare ILDs were presented.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherEuropean Respiratory Society (ERS)-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1183/23120541.00584-2022-
dc.relation.ispartofERJ Open Research, 2023, vol. 9, num. 2-
dc.relation.urihttps://doi.org/10.1183/23120541.00584-2022-
dc.rightscc by-nc (c) SKarampitsakos, Theodoros et al, 2023-
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationMalalties del pulmó-
dc.subject.classificationInvestigació mèdica-
dc.subject.otherPulmonary diseases-
dc.subject.otherMedicine research-
dc.titleERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-05-29T10:58:48Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid37077550-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
00584-2022.full.pdf558.84 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons